Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	140.84B
Revenue (ttm)	16.00B
Net Income (ttm)	896.41M
Shares Out	315.88M
EPS (ttm)	3.09
PE Ratio	144.49
Forward PE	121.98
Dividend	n/a
Ex-Dividend Date	n/a

Volume	318,730
Average Volume	530,613
Open	448.60
Previous Close	442.80
Day's Range	442.00 - 458.45
52-Week Range	365.70 - 464.00
Beta	n/a
RSI	60.51
Earnings Date	Aug 8, 2025

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 4,214
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In 2023, Dr. Agarwal's Health Care's revenue was 13.32 billion, an increase of 30.86% compared to the previous year's 10.18 billion. Earnings were 830.61 million, a decrease of -11.73%.